Corcept Therapeutics Inc
SWB:HTD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Corcept Therapeutics Inc
SWB:HTD
|
US |
|
SoFi Technologies Inc
F:6B0
|
US |
|
Olam Group Ltd
SGX:VC2
|
SG |
|
T
|
Telefonica SA
XMUN:TNE2
|
ES |
|
E
|
EverCommerce Inc
NASDAQ:EVCM
|
US |
|
W
|
Wheaton Precious Metals Corp
XMUN:SII
|
CA |
|
B
|
Bank of America Corp
DUS:NCB
|
US |
|
N
|
Nintendo Co Ltd
LSE:0R1E
|
JP |
|
R
|
RF Industries Ltd
F:RF5
|
US |
Wall St Price Targets
HTD Price Targets Summary
Corcept Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for HTD is 87.29 EUR with a low forecast of 36.07 EUR and a high forecast of 123.75 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is HTD's stock price target?
Price Target
87.29
EUR
According to Wall Street analysts, the average 1-year price target for HTD is 87.29 EUR with a low forecast of 36.07 EUR and a high forecast of 123.75 EUR.
What is the Revenue forecast for Corcept Therapeutics Inc?
Projected CAGR
20%
Over the last 13 years, the compound annual growth rate for Revenue has been 52%. The projected CAGR for the next 8 years is 20%.
What is the Gross Profit forecast for Corcept Therapeutics Inc?
Projected CAGR
20%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 52%. The projected CAGR for the next 8 years is 20%.
What is the Operating Income forecast for Corcept Therapeutics Inc?
Projected CAGR
65%
The compound annual growth rate for Operating Income over the next 8 years is 65%.
What is the Pre-Tax Income forecast for Corcept Therapeutics Inc?
Projected CAGR
150%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 150%.
What is the Net Income forecast for Corcept Therapeutics Inc?
Projected CAGR
46%
The compound annual growth rate for Net Income over the next 8 years is 46%.
